Previous 10 | Next 10 |
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...
Palm Beach, FL – March 17, 2021 – While many industries have suffered during the global pandemic, there are those few whose fortunes are being made because of COVID. The Personal Protective Equipment Market is one of the latter industries. The mass spread infection scale of CO...
Co-Diagnostics went public in 2017 with a proprietary infectious disease testing technology and a clever strategy. During its early rollout, Co-Diagnostics' strategy failed to generate noticeable revenues. As 2020 unfolded, the pandemic both validated Co-Diagnostics' technology an...
LOS ANGELES / USA News Group / As regulators in differing markets around the world continue to work on plans surrounding Covid-19 that will either open up their markets or lock them down further, a central component to all of these decisions is the efficacy of diagnostic tests. Debate r...
Co-Diagnostics to Present Point-of-Care and At Home Testing Platform at Infectious Disease Diagnostics Virtual Conference PR Newswire SALT LAKE CITY , March 10, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diag...
Co-Diagnostics to Discuss Recent Company Advances at H.C. Wainwright Global Life Sciences Virtual Conference PR Newswire SALT LAKE CITY , March 8, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ-CM: CODX) (the "Company"), a molecular diagnostics company wit...
Co-Diagnostics ([[CODX]] +1.3%) announces the development of a new point-of-care/at home PCR diagnostic testing, screening and surveillance platform designed to perform Covid-19 testing at businesses, schools, homes, hotels, cruise ships, airports, airplanes and other locations.The compa...
Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology Proprietary platform includes countertop device being developed for Co-Diagnostics by world experts in rapid PCR PR Newswire ...
A rapid response COVID-19 saliva test from Clinical Reference Laboratory, a partner of Co-Diagnostics (CODX), is now available through Walgreens (WBA) Find Care.The test, HealthConfirm, which has received FDA Emergency Use Authorization, allows consumers to self-administer a PCR-based test at...
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care® Clinical Reference Laboratory's FDA-authorized saliva-based PCR test uses technology developed by Co-Diagnostics to detect SARS-CoV...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...